Primary end point analysis from the ESSENCE trial: Enoxaparin vs unfractionated heparin in unstable angina and non-Q wave infarction.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- October 15, 1996
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Circulation Journal